FeNO testing is transforming the way asthma and respiratory conditions are diagnosed and managed. By providing a fast, non-invasive measure of airway inflammation, this innovative technology enables more accurate diagnoses, personalised treatment plans, and improved patient outcomes. As portable FeNO devices become more accessible, they are playing an increasingly important role in modern, point-of-care respiratory care.

Advanced IgE testing is transforming how atopic dermatitis is understood and diagnosed. By analysing hundreds of allergen components, researchers reveal hidden cross-reactivity patterns that help explain persistent eczema, asthma, and allergic rhinitis. This insight supports more precise, personalised allergy diagnosis using modern molecular testing.